rc 3095 has been researched along with bim 23127 in 1 studies
Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (bim 23127) | Trials (bim 23127) | Recent Studies (post-2010) (bim 23127) |
---|---|---|---|---|---|
108 | 2 | 26 | 15 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunetto, AL; Brunetto, AT; de Farias, CB; Fratini, L; Ghisleni, EC; Gregianin, LJ; Jaeger, M; Roesler, R; Schwartsmann, G | 1 |
1 other study(ies) available for rc 3095 and bim 23127
Article | Year |
---|---|
Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Bombesin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Peptide Fragments; Peptides, Cyclic; Receptors, Bombesin | 2016 |